MoneyWorks4Me

Sanofi India informs about change in management

17 Oct 2023 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 (‘Listing Regulations’), Sanofi India has informed that with effect from 16th October 2023, Surabhi Kaul is appointed as India People Director and will be part of the Senior Management Personnel of the Company. Further, the information required in terms of Regulation 30 read with Schedule Ill - Para A (7) of Part A of the SEBI Listing Regulations and SEBI Circular bearing Ref. No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July, 2023 is enclosed as ‘Annexure-I’ to this letter.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..